Crossmark

Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety

Crossref DOI link: https://doi.org/10.1016/j.aller.2020.03.011

Published Print: 2020-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ocak, M.

Soyer, O.

Buyuktiryaki, B.

Sekerel, B.E.

Sahiner, U.M. http://orcid.org/0000-0003-0088-913X
License Information

Text and Data Mining valid from 2020-07-01
More Information

This article is maintained by: Elsevier

Article Title: Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety

Journal Title: Allergologia et Immunopathologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aller.2020.03.011

Content Type: article

Copyright: © 2020 SEICAP. Published by Elsevier España, S.L.U. All rights reserved.